Peak6 Investments LLC Crispr Therapeutics Ag Call Options Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $4.23 Million - $5.95 Million	-94,900 Reduced 51.08%	90,900 $4.27 Million
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $5.23 Million - $6.97 Million	-102,300 Reduced 35.51%	185,800 $10 Million
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $16.1 Million - $23.7 Million	265,600 Added 1180.44%	288,100 $19.6 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $335,994 - $627,966	8,700 Added 63.04%	22,500 $1.41 Million
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $1.39 Million - $1.81 Million	-30,700 Reduced 68.99%	13,800 $626,000
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $395,577 - $616,707	9,100 Added 25.71%	44,500 $2.5 Million
Q1 2023 May 12, 2023	SELL	$41.0 - $56.12 $1.62 Million - $2.22 Million	-39,600 Reduced 52.8%	35,400 $1.6 Million
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $2.32 Million - $3.88 Million	-59,100 Reduced 44.07%	75,000 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $2.71 Million - $3.71 Million	44,300 Added 49.33%	134,100 $8.76 Million
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $933,767 - $1.59 Million	-21,600 Reduced 19.39%	89,800 $5.46 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $1.4 Million - $2.08 Million	26,300 Added 30.9%	111,400 $6.99 Million
Q4 2021 Feb 11, 2022	SELL	$70.09 - $111.29 $8.03 Million - $12.8 Million	-114,600 Reduced 57.39%	85,100 $6.45 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $5.11 Million - $7.27 Million	46,400 Added 30.27%	199,700 $22.4 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $13.8 Million - $22.2 Million	137,300 Added 858.13%	153,300 $24.8 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $1.1 Million - $2.08 Million	-9,900 Reduced 38.22%	16,000 $1.95 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $2.06 Million - $4.49 Million	25,900 New	25,900 $3.97 Million
Q3 2019 Nov 08, 2019	SELL	$40.99 - $52.56 $647,642 - $830,448	-15,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $560,110 - $761,560	15,800 New	15,800 $744,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$317 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$300 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$120 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$119 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$119 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.12B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account